Microenvironment-induced cancer metastasis

International Journal of Radiation Biology

Volumn 76, Issue 5, 2000, Pages 589-605

  Rofstad, E K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLUCOSE; LACTIC ACID; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CANCER RADIOTHERAPY; CELL DEATH; DELETION MUTANT; DNA STRAND BREAKAGE; DNA TRANSCRIPTION; GENE ACTIVATION; GENE AMPLIFICATION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IONIZING RADIATION; LACTATE BLOOD LEVEL; METASTASIS; MICROVASCULATURE; MOUSE; NONHUMAN; OXYGEN TENSION; PH; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; RAT; REOXYGENATION; REVIEW; SENSOR; SIGNAL TRANSDUCTION; SOFT TISSUE SARCOMA; STRESS; TUMOR GROWTH; UTERINE CERVIX CARCINOMA;

ANIMALIA;

EID: 0034037286     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530000138259     Document Type: Review

References (205)

1. ACKER, H., 1994, Mechanism and meaning of cellular oxygen sensing in the organism. Respiratory Physiology, 95, 1-10.
2. ADAMS, G. E., HASAN, N. M. and JOINER, M. C., 1997, Radiation, hypoxia and genetic stimulation: implications for future therapies. Radiotherapy and Oncology, 44, 101-109.
3. ALITALO, K. and SCHWARB, M., 1986, Oncogene amplification in tumor cells. Advances in Cancer Research, 47, 235-259.
4. ANDERSON, P. and DISCHE, S., 1981, Local tumor control and the subsequent incidence of distant metastatic disease. International Journal of Radiation Oncology, Biology, Physics, 7, 1645-1648.
5. BARRETT, J. C., TSUTSUI, T., TLSTY, T. D. and OSHIMURA, M., 1990, Role of growth instability in carcinogenesis. In Genetic Mechanisms in Carcinogenesis and Tumor Progression, edited by C. C. Harris and L. A. Liotta (New York: Wiley-Liss), pp. 97-114.
6. BARSKY, S. H., STERNLICHT, M. D., SAFARIANS, S., NGUYEN, M., CHIN, K., STEWART, S. D., HITI, A. L. and GRAY, J. W., 1997, Evidence of a dominant transcriptional pathway which regulates an undifferentiated and complete metastatic phenotype. Oncogene, 15, 2077-2091.
7. BECK, I., WEINMANN, R. and CARO, J., 1993, Characterization of hypoxia-responsive enhancer in the human erythropoietin gene shows presence of hypoxia-inducible 120-kD nuclear DNA-binding protein in erythropoietin-producing and nonproducing cells. Blood, 82, 704-711.
8. BEDFORD, J. S., 1991, Sublethal damage, potentially lethal damage, and chromosomal aberrations in mammalian cells exposed to ionizing radiations. International Journal of Radiation Oncology, Biology, Physics, 21, 1457-1469.
9. BERGERS, G., JAVAHERIAN, K., LO, K.-M., FOLKMAN, J. and HANAHAN, D., 1999, Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science, 284, 808-812.
10. BICKNELL, R. and HARRIS, A. L., 1996, Mechanisms and therapeutic implications of angiogenesis. Current Opinion in Oncology, 8, 60-65.
11. BLANCHER, C. and HARRIS, A. L., 1998, The molecular basis of the hypoxia response pathway: tumour hypoxia as a therapy target. Cancer and Metastasis Reviews, 17, 187-194.
12. BLOOD, C. H. and ZETTER, B. R., 1990, Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochimica and Biophysica Acta, 1032, 89-118.
13. BOOTHMAN, D. A., BOUVARD, I. and HUGHES, E. N., 1989, Identification and characterization of X-ray-induced proteins in human cells. Cancer Research, 49, 2871-2879.
14. BOURRAT-FLOECK, B., GROEBE, K. and MUELLER-KLIESER, W., 1991, Biological response of multicellular EMT6 spheroids to exogenous lactate. International Journal of Cancer, 47, 792-799.
15. BRIZEL, D. M., SCULLY, S. P., HARRELSON, J. M., LAYFIELD, L. J., BEAN, J. M., PROSNITZ, L. R. and DEWHIRST, M. W., 1996a, Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Research, 56, 941-943.
16. BRIZEL, D. M., SCULLY, S. P., HARRELSON, J. M., LAYFIELD, L. J., DODGE, R. K., CHARLES, C., SAMULSKI, T. V., PROSNITZ, L. R. and DEWHIRST, M. W., 1996b, Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Research, 56, 5347-5350.
17. BRIZEL, D. M., SIBLEY, G. S., PROSNITZ, L. R., SCHER, R. L. and DEWHIRST, M. W., 1997, Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. International Journal of Radiation Oncology, Biology, Physics, 38, 285-289.
18. BROWN, J. M., 1979, Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. British Journal of Radiology, 52, 650-656.
19. BROWN, J. M. and GIACCIA, A. J., 1998, The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Research, 58, 1408-1416.
20. BUNN, H. F. and POYTON, R. O., 1996, Oxygen sensing and molecular adaptation to hypoxia. Physiological Reviews, 76, 839-885.
21. CARMELIET, P., DOR, Y., HERBERT, J.-M., FUKUMARA, D., BRUSSELMANS, K., DEWERCHIN, M., NEEMAN, M., BONO, F., ABRAMOVITCH, R., MAXWELL, P., KOCH, C. J., RATCLIFFE, P., MOONS, L., JAIN, R. K., COLLEN, D. and KESHET, E., 1998, Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature, 394, 485-490.
22. CHAE, H. P., JARVIS, L. J. and UCKUN, F. M., 1993, Role of tyrosine phosphorylation in radiation-induced activation of c-jun protooncogene in human lympho-hematopoietic precursor cells. Cancer Research, 53, 447-451.
23. CHALMERS, I. J., HOFLER, H. and ATKINSON, M. J., 1999, Mapping of a cadherin gene cluster to a region of chromosome 5 subject to frequent allelic loss in carcinoma. Genomics, 57, 160-163.
24. CHENG, K. C., CAHILL, D. S., KASAI, H., NISHIMURA, S. and LOEB, L. A., 1992, 8-hydroxy-guanine, an abundant form of oxidative DNA damage, causes G-T and A C substitutions. Journal of Biological Chemistry, 267, 166-172.
25. CHENG, K. C. and LOEB, L. A., 1993, Genomic instability and tumor progression: mechanistic considerations. Advances in Cancer Research, 60, 121-156.
26. COLEMAN, C. N., 1993, Beneficial liaisons: radiobiology meets cellular and molecular biology. Radiotherapy and Oncology, 28, 1-15.
27. COLLARD, J. G., VAN DE POLL, M., SCHEFFER, A., ROOS, E., HOPMAN, A. H. M., VAN KESSEL, A. H. M. G. and VAN DONGEN, J. J. M., 1987, Location of genes involved in invasion and metastasis on human chromosome 7. Cancer Research, 47, 6666-6670.
28. COLLINS, M. K., FURLONG, I. J., MALDE, P., ASCASO, R., OLIVER, J. and LOPEZ-RIVAS, A., 1996, An apoptotic endonuclease activated either by decreasing pH or by increasing calcium. Journal of Cell Science, 109, 2393-2399.
29. CUVIER, C., JANG, A. and HILL, R. P., 1997, Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion. Clinical and Experimental Metastasis, 15, 19-25.
30. CZUBAYKO, F., LIAUDET-COOPMAN, E. D. E., AIGNER, A., TUVESON, A. T., BERCHEM, G. J. and WELLSTEIN, A., 1997, A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nature Medicine, 3, 1137-1140.
31. DACHS, G. U. and STRATFORD, I. J., 1996, The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy. British Journal of Cancer, 74 (Suppl XXVII), s126-s132.
32. DATTA, R., RUBIN, E., SUKHATME, V. P., QURESHI, S. A., HALLAHAN, D., WEICHSELBAUM, R. R. and KUFE, D. W., 1992, Ionizing radiation activates transcription of the EGR1 gene via CArG elements. Proceedings of the National Academy of Sciences, USA, 89, 10149-10153.
33. 6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. Proceedings of the National Academy of Sciences, USA, 90, 2419-2422.
34. DEFATTA, R. J., TURBAT-HERRERA, E. A., LI, B. D. L., ANDERSON, W. and DE BENEDETTI, A., 1999, Elevated expression of eIF4E in confined early breast cancer lesions: possible role of hypoxia. International Journal of Cancer, 80, 516-522.
35. DE JAEGER, K., MERLO, F. M., KAVANAGH, M.-C., FYLES, A. W., HEDLEY, D. and HILL., R. P., 1998, Heterogeneity of tumor oxygenation: relationship to tumor necrosis, tumor size, and metastasis. International Journal of Radiation Oncology, Biology, Physics, 42, 717-721.
36. DESBAILLETS, I., DISERENS, A.-C., DE TRIBOLET, N., HAMOU, M.-F. and VAN MEIR, E. G., 1999, Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene, 18, 1447-1456.
37. DISCHER, D. J., BISHOPRIC, N. H., WU, X., PETERSON, C. A. and WEBSTER, K. A., 1998, Hypoxia regulates β-enolase and pyruvate kinase-M promoters by modulating Sp1/Sp3 binding to a conserved GC element. Journal of Biological Chemisty, 273, 26087-26093.
38. DVORAK, H. F., 1986, Tumours: wounds that do not heal. Similarity between tumor stroma generation and wound healing. New England Journal of Medicine, 315, 1650-1658.
39. DVORAK, H. F., ORENSTEIN, N. S., CARVALHO, A. C., CHURCHILL, W. H., DVORAK, A. M., GALLI, S. J., FEDER, J., BITZER, A. M., RYPYCS, J. and GIOVINCO, P., 1979, Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. Journal of Immunology, 122, 166-174.
40. ELIAS, H., HENNING, A. and SCHWARZ, D. E., 1971, Stereology: applications to biomedical research. Histology Reviews, 51, 158-200.
41. FAGUNDES, H., PEREZ, C. A., GRIGSBY, P. W. and LOCKETT, M. A., 1992, Distant metastases after irradiation alone in carcinoma of the uterine cervix. International Journal of Radiation Oncology, Biology, Physics, 24, 197-204.
42. FERRARA, N., 1996, Vascular endothelial growth factor. European Journal of Cancer, 32A, 2413-2422.
43. FIDLER, I. J., 1990, Critical factors in the biology of human cancer metastasis: twenty-eighth G. H. A. Clowes memorial award lecture. Cancer Research, 50, 6130-6138.
44. FIDLER, I. J. and ELLIS, L. M., 1994, The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell, 79, 185-188.
45. FISHER, B., ANDERSON, T., FISHER, E. R., REDMOND, C., WICKERHAM, D. L., WOLMARK, N., MAMOUNAS, E. P., DEUTSCH, M. and MARGOLESE, R., 1991, Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet, 338, 327-331.
46. 2 measured with 'thick' needle probes. Funktionsanalyse Biologische Systeme, 15, 155-166.
47. FOLKMAN, J., 1990, What is the evidence that tumors are angiogenesis dependent? Journal of the National Cancer Institute, 82, 4-6.
48. FOLKMAN, J., 1995, Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine, 1, 27-31.
49. FORSYTHE, J. A., JIANG, B. H., IVER, N. V., AGANI, F., LEUNG, S. W., KOSS, R. D. and SEMENZA, G. L., 1996, Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Molecular and Cellular Biology, 16, 4604-4613.
50. FOULDS, L., 1975, Neoplastic Development (London: Academic Press).
51. FYLES, A. W., MILOSEVIC, M., PINTILE, M. and HILL, R. P., 1998a, Cervix cancer oxygenation measured following external radiation therapy. International Journal of Radiation Oncology, Biology, Physics, 42, 751-753.
52. FYLES, A. W., MILOSEVIC, M., WONG, R., KAVANAGH, M.-C., PINTILE, M., SUN, A., CHAPMAN, W., LEVIN, W., MANCHUL, L., KEANE, T. J. and HILL, R. P., 1998b, Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiotherapy and Oncology, 48, 149-156.
53. GIACCIA, A. J., 1996, Hypoxic stress proteins: survival of the fittest. Seminars in Radiation Oncology, 6, 46-58.
54. GOLDBERG, M. A., DUNNING, S. P. and BUNN, H. F., 1988, Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science, 242, 1412-1415.
55. GOTTLIEB, R. A., GIESING, H. A., ENGLER, R. L. and BABIOR, B. M., 1995, The acid deoxyribo-nuclease of neutrophils: a possible participant in apoptosis-associated genome destruction. Blood, 86, 2414-2418.
56. GRAEBER, T. G., OSMANIAN, C., JACKS, T., HOUSMAN, D. E., KOCH, C. J., LOWE, S. W. and GIACCIA, A. J., 1996, Hypoxia-mediatcd selection of cells with diminished apoptotic potential in solid tumours. Nature, 379, 88-91.
57. 1-phase checkpoint by low-oxygen conditions is independent of p53 status. Molecular and Cellular Biology, 14, 6264-6277.
58. GRAHAM, C. H., FORSDIKE, J., FITZGERALD, C. J. and MACDONALD-GOODFELLOW, S., 1999, Hypoxia-mediatcd stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. International Journal of Cancer, 80, 617-623.
59. GRIFFITHS, L., DACHS, G. U., BICKNELL, R., HARRIS, A. L. and STRATFORD, I. J., 1997, The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown m vitro and in vivo. Cancer Research, 57, 570-572.
60. GUILLEMIN, K. and KRASNOW, M. A., 1997, The hypoxic response: huffing and HIFing. Cell, 89, 9-12.
61. GULLEDGE, C. J. and DEWHIRST, M. W., 1996, Tumor oxygenation: a matter of supply and demand. Anticancer Research, 16, 741-750.
62. GULLINO, P. M., 1975, Extracellular compartments of solid tumors. In Cancer, Vol. 3, edited by F. F. Becker (New York: Plenum Press), pp. 327-354.
63. HALLAHAN, D. R., VIRUDACHALAM, S., SHERMAN, M. L., HUBERMAN, E., KUFE, D. W. and WEICHSELBAUM, R. R., 1991, Tumor necrosis factor gene expression is mediated by protein kinase C following activation by ionizing radiation. Cancer Research, 51, 4565-4569.
64. HART, I. R., GOODE, N. T. and WILSON, R. E., 1989, Molecular aspects of the metastatic cascade. Biochimica and Biophysica Acta, 989, 65-84.
65. HAYWARD, J. and CALEFFI, M., 1987, The significance of local control in the primary treatment of breast cancer. Archives of Surgery, 122, 1244-1247.
66. HILL, R. P., 1990, Tumor progression: potential role of unstable genomic changes. Cancer Metastasis Reviews, 9, 137-147.
67. HILL, R. P., BRAIL, L. H., JANG, A. and DE JAEGER, K., 1999, Hypoxia and metastasis. International Workshop: The Tumour Microenvironment, University of Ulster at Jordanstown, Newtownabbey, Northern Ireland, 15-17 July 1999, Abstract 3.3.
68. 2 predicts survival in advanced cancer of the uterine cervix. Radiotherapy and Oncology, 26, 45-50.
69. HÖCKEL, M., SCHLENGER, K., ARAL, B., MITZE, M., SCHÄFFER, U. and VAUPEL, P., 1996, Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Research, 56, 4509-4515.
70. HÖCKEL, M., SCHLENGER, K., HÖCKEL, S., ARAL, B., SCHÄFFER, U. and VAUPEL, P., 1998, Tumor hypoxia in pelvic recurrences of cervical cancer. International Journal of Cancer, 79, 365-369.
71. HÖCKEL, M., SCHLENGER, K., HÖCKEL, S. and VAUPEL, P., 1999, Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Research, 59, 4525-4528.
72. 2 tension measurements. Cancer Research, 51, 6098-6102.
73. HÖCKEL, M., VORNDRAN, B., SCHLENGER, K., BAUSSMANN, E. and KNAPSTEIN, P. G., 1993b, Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix. Gynecologic Oncology, 51, 141-149.
74. HORSMAN, M. R., 1995, Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. Acta Oncologica, 34, 571-587.
75. HUANG, L. E., ARANY, Z., LIVINGSTON, D. M. and BUNN, H. F., 1996, Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit. Journal of Biological Chemistry, 271, 32253-32259.
76. JANG, A. and HILL, R. P., 1997, An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells. Clinical and Experimental Metastasis, 15, 469-483.
77. JANSSEN, Y. M. W., VAN HOUTEN, B., BORM, P. J. A. and MOSSMAN, B. T., 1993, Biology of disease. Cell and tissue responses to oxidative damage. Laboratory Investigation, 69, 261-274.
78. JIANG, B.-H., AGANI, F., PASSANITI, A. and SEMENZA, G. L., 1997, V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Research, 57, 5328-5335.
79. 2 tension. American Journal of Physiology, 271, C1172-C1180.
80. KALLIO, P. J., PONGRATZ, I., GRADIN, K., MCGUIRE, J. and POELLINGER, R., 1997, Activation of hypoxia-inducible factor 1-alpha-posttranscriptional regulation and conformational change by recruitment of the ARNT transcription factor. Proceedings of the National Academy of Sciences of the United States of America, 94, 5667-5672.
81. KALLMAN, R. F., 1972, The phenomenon of reoxygenation and its implications for fractionated radiotherapy. Radiology, 105, 135-142.
82. KATO, Y., NAKAYAMA, Y., UMEDA, M. and MIYAZAKI, K., 1992, Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. Journal of Biological Chemistry, 267, 11424-11430.
83. KERBEL, R. S., WAGHORNE, C., KORCZAK, B., LAGARDE, A. and BREITMAN, M. L., 1988, Clonal dominance of primary tumours by metastatic cells: genetic analysis and biological implications. Cancer Surveys, 7, 597-629.
84. KIM, C. Y., TSAI, M. H., OSMANIAN, C., GRAEBER, T. G., LEE, J. E., GIFFARD, R. G., DIPAOLO, J. A., PEEHL, D. M. and GIACCIA, A. J., 1997, Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions. Cancer Research, 57, 4200-4204.
85. KINZLER, K. W. and VOGELSTEIN, B., 1996a, Lessons form hereditary colorectal cancer. Cell, 87, 159-170.
86. KANZLER, K. W. and VOGELSTEIN, B., 1996b, Life (and death) in a malignant tumour. Nature, 379, 19-20.
87. KIRSCHMANN, D. A., SEFTOR, E. A., NIEVA, D. R., MARIANO, E. A. and HENDRIX, M. J., 1999, Differentially expressed genes associated with the metastatic phenotype in breast cancer. Breast Cancer Research and Treatment, 55, 127-136.
88. KLEMPT, N. D., SIRIMANNE, E., GUNN, A. J., KLEMPT, M., SINGH, K., WILLIAMS, C. and GLUCKMAN, P. D., 1992, Hypoxia-ischemia induces transforming growth factor β1 messenger RNA in the infant rat brain. Molecular Brain Research, 13, 93-101.
89. KOONG, A. C., CHEN, E. Y. and GIACCIA, A. J., 1994, Hypoxia causes the activation of nuclear factor κB through phosphorylation of IκBα on tyrosine residues. Cancer Research, 54, 1425-1430.
90. KUMAR, R. and FIDLER, I. J., 1998, Angiogenic molecules and cancer metastasis. In Vivo, 12, 27-34.
91. LADEROUTE, K. R., GRANT, T. D., MURPHY, B. J. and SUTHERLAND, R. M., 1992, Enhanced epidermal growth factor receptor synthesis in human squamous carcinoma cells exposed to low levels of oxygen. International Journal of Cancer, 52, 428-432.
92. LEBOEUF, R. A., KERCKAERT, G. A., AARDEMA, M. J. and GIBSON, D. P., 1990, Multistage neoplastic transformation of Syrian hamster embryo eells cultured at pH 6.7. Cancer Research, 50, 3722-3729.
93. LENGAUER, C., KINZLER, K. W. and VOGELSTEIN, B., 1998, Genetic instabilities in human cancers. Nature, 396, 643-649.
94. LEVINE, A. J., 1993, The tumor suppressor genes. Annual Review of Biochemistry, 62, 623-651.
95. LEVY, A. P., LEVY, N. S. and GOLDBERG, M. A., 1996, Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. Journal of Biological Chemistry, 271, 25492-25497.
96. LIOTTA, L. A., 1988, Gene products which play a role in cancer invasion and metastasis. Breast Cancer Research and Treatment, 11, 113-124.
97. LIOTTA, L. A., 1992, Cancer cell invasion and metastasis. Scientific American, 266, 34-41.
98. LIOTTA, L. A. and STETLER-STEVENSON, W. G., 1991, Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Research, 51, 5054s-5059s.
99. LU, X. and LANE, D. P., 1993, Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell, 75, 765-778.
100. LUCA, M. R. and BAR-ELI, M., 1998, Molecular changes in human melanoma metastasis. Histology and Histopathology, 13, 1225-1231.
101. LUK, C. K., VEINOT-DREBOT, L., TJAN, E. and TANNOCK, I. F., 1990, Effect of transient hypoxia on sensitivity to doxorubicin in human and marine cell lines. Journal of the National Cancer Institute, 82, 684-692.
102. LUU, H. H., ZAGAJA, G. P., DUBAUSKAS, Z., CHEN, S. L., SMITH, R. C., WATABE, K., ICHIKAWA, Y., ICHIKAWA, T., DAVIS, E. M., LE BEAU, M. M. and RINKER-SCHAEFFER, C. W., 1998, Identification of a novel metastasis-suppressor region on human chromosome 12. Cancer Research, 58, 3561-3565.
103. MAHADEVAN, V. and HART, I. R., 1990, Metastasis and angiogenesis. Acta Oncologica, 29, 97-103.
104. MALTEPE, E., SCHMIDT, J. V., BAUNOCH, D., BRADFIELD, C. A. and SIMON, M. C., 1997, Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature, 386, 403-407.
105. MANDRIOTA, S. J., SEGHEZZI, G., VASSALLI, J. D., FERRARA, N., WASI, S., MAZZIERI, R., MIGNATTI, P. and PEPPER, M. S., 1995, Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. Journal of Biological Chemistry, 270, 9707-9716.
106. MARTINEZ-ZAGUILAN, R., SEFTOR, E. A., SEFTOR, R. E. B., CHU, Y.-W., GILLIES, R. J. and HENDRIX, M. J. C., 1996, Acidic pH enhances the invasive behavior of human melanoma cells. Clinical and Experimental Metastasis, 14, 176-186.
107. MARX, E., MUELLER-KLIESER, W. and VAUPEL, P., 1988, Lactate-induced inhibition of tumor cell proliferation. International Journal of Radiation Oncology, Biology, Physics, 14, 947-955.
108. MAXWELL, P. H., DACHS, G. U., GLEADLE, J. M., NICHOLLS, L. G., HARRIS, A. L., STRATFORD, I. J., HANKINSON, O., PUGH, C. W. and RATCLIFFE, P. J., 1997, Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proceedings of the National Academy of Sciences of the United States of America, 94, 8104-8109.
109. MAZURE, N. M., CHEN, E. Y., YEH, P., LADEROUTE, K. R. and GIACCIA, A. J., 1996, Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Research, 56, 3436-3440.
110. MIELE, M. E., ROBERTSON, G., LEE, J. H., COLEMAN, A., MCGARY, C. T., FISHER, P. B., LUGO, T. G. and WELCH, D. R., 1996, Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6. Molecular Carcinogenesis, 15, 284-299.
111. MORANA, S. J., WOLF, C. M., LI, J., REYNOLDS, J. E., BROWN, M. K. and EASTMAN, A., 1996, The involvement of protein phosphatases in the activation of ICE/CED-3 protease, intracellular acidification, DNA digestion, and apoptosis. Journal of Biological Chemistry, 271, 18263-18271.
112. MORISSET, M., CAPONY, F. and ROCHEFORT, H., 1986, The 52-kDa estrogen-induced protein secreted by MCF-7 cells is a lysosomal acidic protease. Biochemical and Biophysical Research Communications, 138, 102-109.
113. MOSSER, D. D., KOTZBAUER, P. T., SARGE, K. D. and MORIMOTO, R. I., 1990, In vitro activation of heat shock transcription factor DNA-binding by calcium and biochemical conditions that affect protein conformation. Proceedings of the National Academy of Sciences of the United States of America, 87, 3748-3752.
114. MUELLER-KLIESER, W., KROEGER, M., WALENTA, S. and ROFSTAD, E. K., 1991, Comparative imaging of structure and metabolites in tumours. International Journal of Radiation Biology, 60, 147-159.
115. MUELLER-KLIESER, W., WALENTA, S., PASCHEN, W., KALLINOWSKI, F. and VAUPEL, P., 1988, Metabolic imaging in microregions of tumors and normal tissues with bioluminescence and photon counting. Journal of the National Cancer Institute, 80, 842-848.
116. MUSCHEL, R. and LIOTTA, L. A., 1988, Role of oncogenes in metastases. Carcinogenesis, 9, 705-710.
117. NAGY, J. A., MASSE, E. M., HERZBERG, K. T., MEYERS, M. S., YEO, K. T., YEO, T. K., SIOUSSAT, T. M. and DVORAK, H. F., 1995, Pathogenesis of ascites tumor growth. Vascular permeability factor, vascular hyperpermeability and ascites fluid accumulation. Cancer Research, 55, 360-368.
118. NICOLSON, G. L., 1987, Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Research, 47, 1473-1487.
119. NICOLSON, G. L., 1993, Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Experimental Cell Research, 204, 171-180.
120. NOEL, A., GILLES, C., BAJOU, K., DEVY, L., KEBERS, F., LEWALLE, J. M., MAQUOI, E., MUNAUT, C., REMACLE, A. and FOIDART, J. M., 1997, Emerging roles for proteinases in cancer. Invasion and Metastasis, 17, 221-239.
121. NORDSMARK, M., OVERGAARD, M. and OVERGAARD, J., 1996, Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiotherapy and Oncology, 41, 31-39.
122. NOWELL, P. C., 1976, The clonal evolution of tumor cell populations. Science, 194, 23-28.
123. NOWELL, P. C., 1986, Mechanisms of tumor progression. Cancer Research, 46, 2203-2207.
124. NOWELL, P. C., 1989, Chromosomal and molecular clues to tumor progression. Seminars in Oncology, 16, 116-127.
125. ONODA, J. M., PIECHOKI, M. P. and HONN, H. V., 1992, Radiation-induced increased expression of the αII/β3 integrin in melanoma cells: effects on metastatic potential. Radiation Research, 130, 281-288.
126. OTTO, E., MCCORD, S. and TLSTY, T. D., 1989, Increased incidence of CAD gene amplification in tumorigenic rat lines as an indicator of genomic instability of neoplastic cells. Journal of Biological Chemistry, 264, 3390-3396.
127. PIGOTT, K. H., HILL, S. A., CHAPLIN, D. J. and SAUNDERS, M. I., 1996, Microregional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry. Radiotherapy and Oncology, 40, 45-50.
128. PLOUET, J., SCHILLING, J. and GOSPODAROWICZ, D., 1989, Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO Journal, 8, 3801-3806.
129. POUYSSÉGUR, J., SHIU, R. P. C. and PASTAN, I., 1977, Induction of two transformation-sensitive membrane polypeptides in normal fibroblasts by a block in glycoprotein synthesis or glucose deprivation. Cell, 11, 941-947.
130. RAK, J., MITSUHASHI, Y., BAYKO, L., FILMUS, J., SHIRASAWA, S., SASAZUKI, T. and KERBEL, R. S., 1995, Mutant ras oncogenes up-regulate VEGF/VPF expression - implications for induction and inhibition of tumor angiogenesis. Cancer Research, 55, 4575-4580.
131. RAMSAMOOJ, P., KASID, U. and DRITSCHILO, A., 1992, Differential expression of proteins in radioresistant and radiosensitive human squamous carcinoma cells. Journal of the National Cancer Institute, 84, 622-628.
132. RAMSAY, J., SUIT, H. D. and SEDLACEK, R., 1988, Experimental studies of the incidence of metastases after failure of radiation treatment and the effect of salvage surgery. International Journal of Radiation Oncology, Biology, Physics, 14, 1165-1168.
133. REYNOLDS, T. Y., ROCKWELL, S. and GLAZER, P. M., 1996, Genetic instability induced by the tumor microenvironment. Cancer Research, 56, 5754-5757.
134. RICE, G. C., HOY, C. and SCHIMKE, R. T., 1986, Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proceedings of the National Academy of Sciences of the United States of America, 83, 5978-5982.
135. ROFSTAD, E. K., 1989, Hypoxia and reoxygenation in human melanoma xenografts. International Journal of Radiation Oncology, Biology, Physics, 17, 81-89.
136. ROFSTAD, E. K. and DANIELSEN, T., 1998, Hypoxia-induced angiogenesis and vascular endothelial growth factor secretion in human melanoma. British Journal of Cancer, 77, 897-902.
137. ROFSTAD, E. K. and DANIELSEN, T., 1999, Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis. British Journal of Cancer, 80, 1697-1707.
138. ROYDS, J. A., DOWER, S. K., QWARNSTROM, E. E. and LEWIS, C. E., 1998, Response of tumour cells to hypoxia: role of p53 and NFκB. Journal of Clinical Pathology: Molecular Pathology, 51, 55-61.
139. ROZHIN J., SAMENI, M., SIEGLER, G. and SLOANE, B. F., 1994, Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Research, 54, 6517-6525.
140. RUSSO, C. A., WEBER, T. K., VOLPE, C. M., STOLER, D. L., PETRELLI, N. J., RODRIGUEZ-BIGAS, M., BURHANS, W. C. and ANDERSON, G. R., 1995, An anoxia inducible endonuclease and enhanced DNA breakage as contributors to genomic instability in cancer. Cancer Research, 55, 1122-1128.
141. SAGER, R., 1989, Tumor suppressor genes: the puzzle and the promise. Science, 246, 1406-1412.
142. SALCEDA, S. and CARO, J., 1997, Hypoxia-inducible factor I alpha (HIF-1 alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions - its stabilization by hypoxia depends on redox-induced changes. Journal of Biological Chemistry, 272, 22642-22647.
143. SCHIMKE, R. T., 1992, Gene amplification: what are we learning? Mutation Research, 276, 145-149.
144. SCHIMKE, R. T., ROOS, D. S. and BROWN, P. C., 1987, Amplification of genes in somatic mammalian cells. Methods in Enzymology, 151, 85-104.
145. SCHIRRMACHER, V., 1985, Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies. Advances in Cancer Research, 43, 1-73.
146. SCHLAPPAK, O. K., ZIMMERMANN, A. and HILL, R. P., 1991, Glucose starvation and acidosis: effect on experimental metastalic potential, DNA content and MTX resistance of murine tumour cells. British Journal of Cancer, 64, 663-670.
147. SCHWICKERT, G., WALENTA, S., SUNDFØR, K., ROFSTAD, E. K. and MUELLER-KLIESER, W., 1995, Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Research, 55, 4757-4759.
148. SCIANDRA, J. J. and SUBJECK, J. R., 1983, The effects of glucose on protein synthesis and thermosensitivity in Chinese hamster ovary cells. Journal of Biological Chemistry, 258, 12091-12093.
149. SCOTT, P. A. E., GLEADLE, J. M., BICKNELL, R. and HARRIS, A. L., 1998, Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. International Journal of Cancer, 75, 706-712.
150. SEMENZA, G. L., 1999, Perspectives on oxygen sensing. Cell, 98, 281-284.
151. SENGER, D. R., GALLI, S. J., DVORAK, A. M., PERUZZI, C. A., HARVEY, V. S. and DVORAK, H. F., 1983, Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science, 219, 983-985.
152. SHARMA, R. C. and SCHIMKE, R. T., 1994, The propensity for gene amplification: a comparison of protocols, cell lines and selection agents. Mutation Research, 304, 243-260.
153. SHELDON, P. W., BEGG, A. C., FOWLER, J. F. and LANSLEY, I. F., 1974, The incidence of lung metastases in C3H mice after treatment of implanted solid tumours with x-rays or surgery. British Journal of Cancer, 30, 342-348.
154. SHWEIKI, D., ITIN, A., SOFFER, D. and KESHET, E., 1992, Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 359, 843-845.
155. SHWEIKI, D., NEEMAN, M., ITIN, A. and KESHET, E., 1995, Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proceedings of the National Academy of Sciences of the United States of America, 92, 768-772.
156. SLOANE, B. F., ROZHIN, J., KREPELA, E., ZIEGLER, G. and SAMENI, M., 1991, The malignant phenotype and cysteine proteinases. Biomedica Biochimica Acta, 50, 549-554.
157. SOBEL, M. E., 1990, Metastasis suppressor genes. Journal of the National Cancer Institute, 82, 267-276.
158. STADLER, P., FELDMANN, H. J., CREIGHTON, C., KAU, R. and MOLLS, M., 1998, Changes in tumor oxygenation during combined treatment with split-course radiotherapy and chemotherapy in patients with head and neck cancer. Radiotherapy and Oncology, 48, 157-164.
159. STARK, G. R., 1986, DNA amplification in drug resistant cells and in tumours. Cancer Surveys, 5, 1-23.
160. STEIN, I., NEEMAN, M., SHWEIKI, D., ITIN, A. and KESHET, E., 1995, Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Molecular and Cellular Biology, 15, 5363-5368.
161. STOLER, D. L., ANDERSON, G. R., RUSSO, C. A., SPINA, A. M. and BEERMAN, T. A., 1992, Anoxia-inducible endonuclease activity as a potential basis of the genomic instability of cancer cells. Cancer Research, 52, 4372-4378.
162. SUIT, H. D., 1982, Potential for improving survival rates for the cancer patient by increasing the efficacy of treatment of the primary lesion. Cancer, 50, 1227-1234.
163. SUIT, H. D., 1992, Local control and patient survival. International Journal of Radiation Oncology, Biology, Physics, 23, 653-660.
164. 2 in cervix carcinoma. Gynecologic Oncology, 64, 230-236.
165. SUNDFØR, K., LYNG, H. and ROFSTAD, E. K., 1998, Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. British Journal of Cancer, 78, 822-827.
166. SUTHERLAND, R. M., 1998, Tumor hypoxia and gene expression. Acta Oncologica, 37, 567-574.
167. SUTHERLAND, R. M., AUSSERER, W. A., MURPHY, B. J. and LADEROUTE, K. R., 1996, Tumor hypoxia and heterogeneity: challenges and opportunities for the future. Seminars in Radiation Oncology, 6, 59-70.
168. TAMULEVICIUS, P. and STREFFER, C., 1995, Metabolic imaging in tumours by means of bioluminescence. British Journal of Cancer, 72, 1102-1112.
169. THOMLINSON, R. H. and GRAY, L. H., 1955, The histological structure of some human lung cancers and the possible implications for radiotherapy. British Journal of Cancer, 9, 539-549.
170. THOMPSON, T. C., 1999, Metastasis-related genes in prostate cancer: the role of caveolin-1. Cancer and Metastasis Reviews, 17, 439-442.
171. TLSTY, T. D., MARGOLIN, B. and LUM, K., 1989, Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbruck fluctuation analysis. Proceedings of the National Academy of Sciences of the United States of America, 86, 9441-9445.
172. TURNER, G. A., 1979, Increased release of tumour cells by collagenase at acid pH: a possible mechanism for metastasis. Experentia, 35, 1657-1658.
173. UNEMORI, E. N., FERRARA, N., BAUER, E. A. and AMENTO, A. P., 1992, Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. Journal of Cellular Physiology, 153, 557-562.
174. 3H-misonidazole to solid human tumors as a measure of tumor hypoxia. International Journal of Radiation Oncology, Biology, Physics, 12, 1263-1267.
175. VAN DER STAPPEN, J. W., WILLIAMS, A. C., MACIEWICZ, R. A. and PARASKEVA, C., 1996, Activation of cathepsin B secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D. International Journal of Cancer, 67, 547-554.
176. VAUPEL, P., 1990, Oxygenation of human tumors. Strahlentherapie und Onkologie, 166, 377-386.
177. VAUPEL, P., KALLINOWSKI, F. and OKUNIEFF, P., 1989, Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Research, 49, 6449-6465.
178. 2 tension measurements. Cancer Research, 51, 3316-3322.
179. VERMEULEN, P. B., GASPARINI, G., FOX, S. B., TOI, M., MARTIN, L., MCCULLOCH, P., PEZZELLA, F., VIALE, G., WEIDNER, N., HARRIS, A. L. and DIRIX, L. Y., 1996, Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. European Journal of Cancer, 32A, 2474-2484.
180. VOLPE, J. P. G., 1988, Genetic instability of cancer: why a metastatic tumor is unstable and a benign tumor is stable. Cancer Genetics and Cytogenetics, 34, 125-134.
181. VON ESSEN, C. F., 1991, Radiation enhancement of metastasis: a review. Clinical and Experimental Metastasis, 9, 77-104.
182. WAGHORNE, C., THOMAS, M., LAGARDE, A., KERBEL, R. S. and BREITMAN, M. L., 1988, Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations. Cancer Research, 48, 6109-6114.
183. WALENTA, S., DELLIAN, M., GOETZ, A. E., KUHNLE, G. E. H. and MUELLER-KLIESER, W., 1992, Pixel-to-pixel correlation between images of absolute ATP concentrations and blood flow in tumours. British Journal of Cancer, 66, 1099-1102.
184. WALENTA, S., SALAMEH, A., LYNG, H., EVENSEN, J. F., MITZE, M., ROFSTAD, E. K. and MUELLER-KLIESER, W., 1997, Correlation of high lactate levels in head and neck tumors with incidence of metastasis. American Journal of Pathology, 150, 409-415.
185. WALENTA, S., WETTERLING, M., LEHRKE, M., SCHWICKERT, G., SUNDFØR, K., ROFSTAD, E. K. and MUELLER-KLIESER, W., 2000, High lactate levels predict likelihood of metastases, tumor regrowth, and patient survival in human cervix cancers. Cancer Research, 60, 916-927.
186. 2 tension. Proceedings of the National Academy of Sciences of the United States of America, 92, 5510-5514.
187. WANG, G. L. and SEMENZA, G. L., 1993, General involvement of hypoxia-inducible factor-1 in transcriptional response to hypoxia. Proceedings of the National Academy of Sciences of the United States of America, 90, 4304-4308.
188. WANG, G. L. and SEMENZA, G. L., 1995, Purification and characterization of hypoxia-inducible factor-I. Journal of Biological Chemistry, 270, 1230-1237.
189. WEICHSELBAUM, R. R., HALLAHAN, D. E., SUKHATME, V. P., DRITSCHILO, A., SHERMAN, M. L. and KUFE, D. W., 1991, Biological consequences of gene regulation after ionizing radiation exposure. Journal of the National Cancer Institute, 83, 480-484.
190. WEIDNER, N., 1993, Tumor angiogenesis: review of current applications in tumor prognostication. Seminars in Diagnostic Pathology, 10, 302-313.
191. WEIDNER, N., 1995, Intratumor microvessel density as a prognostic factor in cancer. American Journal of Pathology, 147, 9-19.
192. WEIDNER, N., SEMPLE, J. P., WELCH, W. R. and FOLKMAN, J., 1991, Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. New England Journal of Medicine, 324, 1-8.
193. WHELAN, S. A. and HIGHTOWER, L. E., 1985, Differential induction of glucose-regulated and heat shock proteins: effects of pH and sulfhydryl-reducing agents on chicken embryo cells. Journal of Cellular Physiology, 125, 251-258.
194. WIKE-HOOLEY, J. L., HAVEMAN, J. and REINHOLD, H. S., 1984, The relevance of tumour pH to the treatment of malignant disease. Radiotherapy and Oncology, 2, 343-366.
195. WILKINSON, D., SANDHU, J. K., BRENEMAN, J. W., TUCKER, J. D. and BIRNBOIM, H. C., 1995, Hprt mutants in a transplantable murine tumour arise more frequently in vivo than in vitro. British Journal of Cancer, 72, 1234-1240.
196. WILLIAMS, A. C., COLLARD, T. J. and PARASKEVA, C., 1999, An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: implications for clonal selection during colorectal carcinogenesis. Oncogene, 18, 3199-3204.
197. WILSON, R. E., KENG, P. C. and SUTHERLAND, R. M., 1989, Drug resistance in Chinese hamster ovary cells during recovery from severe hypoxia. Journal of the National Cancer Institute, 81, 1235-1240.
198. WINDLE, B. E., DRAPER, B. W., YIN, Y., O'GORMAN, S. and WAHL, G. M., 1991, A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. Genes and Development, 5, 160-174.
199. WINDLE, B. E. and WAHL, G. M., 1992, Molecular dissection of mammalian gene amplification: new mechanistic insights revealed by analyses of very early events. Mutation Research, 276, 199-224.
200. WU, X., BISHOPRIC, N. H., DISCHER, D. J., MURPHY, B. J. and WEBSTER, K. A., 1996, Physical and functional sensitivity of zinc finger transcription factors to redox change. Molecular and Cellular Biology, 16, 1035-1046.
201. YAO, K.-S., XANTHOUDAKIS, S., CURRAN, T. and O'DWYER, P. J., 1994, Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Molecular and Cellular Biology, 14, 5997-6003.
202. YOUNG, S. D. and HILL, R. P., 1990, Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. Journal of the National Cancer Institute, 82, 371-380.
203. YOUNG, S. D., MARSHALL, R. S. and HILL, R. P., 1988, Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proceedings of the National Academy of Sciences of the United States of America, 85, 9533-9537.
204. YU, A. E., HEWITT, R. E., CONNOR, E. W. and STETLER-STEVENSON, W. G., 1997, Matrix metalloproteinases. Novel targets for directed cancer therapy. Drugs and Aging, 11, 229-244.
205. ZAGARS, G. K., VON ESCHENBACH, A. C., AYALA, A. G., SCHULTHEISS, T. E. and SHERMAN, N. E., 1991, The influence of local control on metastatic dissemination of prostate cancer treated by external beam megavoltage radiation therapy. Cancer, 68, 2370-2377.